Resultats de la cerca - Michael C. Irizarry

Refinar resultats
  1. 1
    Biomarkers of Alzheimer disease in plasma

    Biomarkers of Alzheimer disease in plasma per Michael C. Irizarry

    Publicat 2004
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  2. 2
    Caffeine protects against combined paraquat and maneb-induced dopaminergic neuron degeneration

    Caffeine protects against combined paraquat and maneb-induced dopaminergic neuron degeneration per Anil Kachroo, Michael C. Irizarry, Michael A. Schwarzschild

    Publicat 2010
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  3. 3
    Induction of the Cholesterol Transporter ABCA1 in Central Nervous System Cells by Liver X Receptor Agonists Increases Secreted Aβ Levels

    Induction of the Cholesterol Transporter ABCA1 in Central Nervous System Cells by Liver X Receptor Agonists Increases Secreted Aβ Levels per Hiroaki Fukumoto, Amy Deng, Michael C. Irizarry, Michael L. Fitzgerald, G. William Rebeck

    Publicat 2002
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  4. 4
    APPSW Transgenic Mice Develop Age-related Aβ Deposits and Neuropil Abnormalities, but no Neuronal Loss in CA1

    APPSW Transgenic Mice Develop Age-related Aβ Deposits and Neuropil Abnormalities, but no Neuronal Loss in CA1 per Michael C. Irizarry, M. McNamara, Kerri L. Fedorchak, Karen Hsiao, Bradley T. Hyman

    Publicat 1997
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  5. 5
    Elevation of Cystatin C in Susceptible Neurons in Alzheimer's Disease

    Elevation of Cystatin C in Susceptible Neurons in Alzheimer's Disease per Amy Deng, Michael C. Irizarry, Roger M. Nitsch, John H. Growdon, G. William Rebeck

    Publicat 2001
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  6. 6
    β-Secretase Activity Increases with Aging in Human, Monkey, and Mouse Brain

    β-Secretase Activity Increases with Aging in Human, Monkey, and Mouse Brain per Hiroaki Fukumoto, Douglas L. Rosene, Mark B. Moss, Susan Raju, Bradley T. Hyman, Michael C. Irizarry

    Publicat 2004
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  7. 7
    Lipoprotein-associated phospholipase A2 and risk of dementia in the Cardiovascular Health Study

    Lipoprotein-associated phospholipase A2 and risk of dementia in the Cardiovascular Health Study per Annette L. Fitzpatrick, Michael C. Irizarry, Mary Cushman, Nancy S. Jenny, C. Gloria, Carol E. Koro

    Publicat 2014
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  8. 8
    Autoantibodies to Redox-modified Oligomeric Aβ Are Attenuated in the Plasma of Alzheimer's Disease Patients

    Autoantibodies to Redox-modified Oligomeric Aβ Are Attenuated in the Plasma of Alzheimer's Disease Patients per Robert D. Moir, Katya A. Tseitlin, Stephanie J. Soscia, Bradley T. Hyman, Michael C. Irizarry, Rudolph E. Tanzi

    Publicat 2005
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  9. 9
    Plasma Amyloid β-Protein and C-reactive Protein in Relation to the Rate of Progression of Alzheimer Disease

    Plasma Amyloid β-Protein and C-reactive Protein in Relation to the Rate of Progression of Alzheimer Disease per Joseph J. Locascio, Hiroaki Fukumoto, Liang Yap, Teodoro Bottiglieri, John H. Growdon, Bradley T. Hyman, Michael C. Irizarry

    Publicat 2008
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  10. 10
    Aβ Deposition Is Associated with Neuropil Changes, but not with Overt Neuronal Loss in the Human Amyloid Precursor Protein V717F (PDAPP) Transgenic Mouse

    Aβ Deposition Is Associated with Neuropil Changes, but not with Overt Neuronal Loss in the Human Amyloid Precursor Protein V717F (PDAPP) Transgenic Mouse per Michael C. Irizarry, Ferdie Soriano, M. McNamara, Keith J. Page, Dale Schenk, Dora Games, Bradley T. Hyman

    Publicat 1997
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  11. 11
    Shorter Telomeres May Mark Early Risk of Dementia: Preliminary Analysis of 62 Participants from the Nurses' Health Study

    Shorter Telomeres May Mark Early Risk of Dementia: Preliminary Analysis of 62 Participants from the Nurses' Health Study per Francine Grodstein, Marieke van Oijen, Michael C. Irizarry, H. Diana Rosas, Bradley T. Hyman, John H. Growdon, Immaculata De Vivo

    Publicat 2008
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  12. 12
    Nigral and Cortical Lewy Bodies and Dystrophic Nigral Neurites in Parkinsonʼs Disease and Cortical Lewy Body Disease Contain α-synuclein Immunoreactivity

    Nigral and Cortical Lewy Bodies and Dystrophic Nigral Neurites in Parkinsonʼs Disease and Cortical Lewy Body Disease Contain α-synuclein Immunoreactivity per Michael C. Irizarry, Whitfield Growdon, Teresa Gómez‐Isla, Kathy L. Newell, Julia M. George, David F. Clayton, Bradley T. Hyman

    Publicat 1998
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  13. 13
    Distinct Pools of β-Amyloid in Alzheimer Disease–Affected Brain

    Distinct Pools of β-Amyloid in Alzheimer Disease–Affected Brain per Joshua R. Steinerman, Michael C. Irizarry, Nikolaos Scarmeas, Susan Raju, Jason Brandt, Marilyn Albert, Deborah Blacker, Bradley T. Hyman, Yaakov Stern

    Publicat 2008
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  14. 14
    Consistency of efficacy results across various clinical measures and statistical methods in the lecanemab phase 2 trial of early Alzheimer’s disease

    Consistency of efficacy results across various clinical measures and statistical methods in the lecanemab phase 2 trial of early Alzheimer’s disease per Shobha Dhadda, Michio Kanekiyo, David Li, Chad J. Swanson, Michael C. Irizarry, Scott Berry, Lynn D. Kramer, Donald A. Berry

    Publicat 2022
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  15. 15
    Plasma Urate and Progression of Mild Cognitive Impairment

    Plasma Urate and Progression of Mild Cognitive Impairment per Michael C. Irizarry, Rema Raman, Michael A. Schwarzschild, Lida M. Becerra, Ronald G. Thomas, Ronald C. Peterson, Alberto Ascherio, Paul Aisen

    Publicat 2008
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  16. 16
    ARIA in patients treated with lecanemab (BAN2401) in a phase 2 study in early Alzheimer's disease

    ARIA in patients treated with lecanemab (BAN2401) in a phase 2 study in early Alzheimer's disease per Lawrence S. Honig, Jerome Barakos, Shobha Dhadda, Michio Kanekiyo, Larisa Reyderman, Michael C. Irizarry, Lynn D. Kramer, Chad J. Swanson, Marwan Sabbagh

    Publicat 2023
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  17. 17
    Rapid Progression from Mild Cognitive Impairment to Alzheimer’s Disease in Subjects with Elevated Levels of Tau in Cerebrospinal Fluid and the <i>APOE </i>ε<i>4</i>/ε<i>4</i> Genotype

    Rapid Progression from Mild Cognitive Impairment to Alzheimer’s Disease in Subjects with Elevated Levels of Tau in Cerebrospinal Fluid and the <i>APOE </i>ε<i>4&l... per Elin Blom, Vilmantas Giedraitis, Henrik Zetterberg, Hiroaki Fukumoto, Kaj Blennow, Bradley T. Hyman, Michael C. Irizarry, Lars‐Olof Wahlund, Lars Lannfelt, Martin Ingelsson

    Publicat 2009
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  18. 18
    Neurotoxic effects of thioflavin S-positive amyloid deposits in transgenic mice and Alzheimer's disease

    Neurotoxic effects of thioflavin S-positive amyloid deposits in transgenic mice and Alzheimer's disease per Brigita Urbanc, Luis Cruz, R. Le, Judith L. Sanders, Karen H. Ashe, Karen Duff, H. Eugene Stanley, Michael C. Irizarry, Bradley T. Hyman

    Publicat 2002
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  19. 19
    Plaque-Induced Abnormalities in Neurite Geometry in Transgenic Models of Alzheimer Disease: Implications for Neural System Disruption

    Plaque-Induced Abnormalities in Neurite Geometry in Transgenic Models of Alzheimer Disease: Implications for Neural System Disruption per Ricky Le, Luis Cruz, Brigita Urbanc, Roger B. Knowles, K. Hsiao-Ashe, Karen Duff, Michael C. Irizarry, H. Eugene Stanley, Bradley T. Hyman

    Publicat 2001
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  20. 20
    Age-Related Amyloid β Deposition in Transgenic Mice Overexpressing Both Alzheimer Mutant Presenilin 1 and Amyloid β Precursor Protein Swedish Mutant Is Not Associated with Global Neuronal Loss

    Age-Related Amyloid β Deposition in Transgenic Mice Overexpressing Both Alzheimer Mutant Presenilin 1 and Amyloid β Precursor Protein Swedish Mutant Is Not Associated with Global N... per Ayano Takeuchi, Michael C. Irizarry, Karen Duff, Takaomi C. Saido, Karen H. Ashe, Masato Hasegawa, David M. A. Mann, Bradley T. Hyman, Takeshi Iwatsubo

    Publicat 2000
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:

Eines de cerca: